KR890003390A - 골다공증 및 관련된 장해의 치료방법 - Google Patents

골다공증 및 관련된 장해의 치료방법 Download PDF

Info

Publication number
KR890003390A
KR890003390A KR1019880010858A KR880010858A KR890003390A KR 890003390 A KR890003390 A KR 890003390A KR 1019880010858 A KR1019880010858 A KR 1019880010858A KR 880010858 A KR880010858 A KR 880010858A KR 890003390 A KR890003390 A KR 890003390A
Authority
KR
South Korea
Prior art keywords
malate
calcium
citrate
calcium citrate
composition
Prior art date
Application number
KR1019880010858A
Other languages
English (en)
Other versions
KR970009582B1 (en
Inventor
앤 코카노우스키 바바라
Original Assignee
원본미기재
노르위치 이튼 파마슈티칼즈, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 노르위치 이튼 파마슈티칼즈, 인코포레이티드 filed Critical 원본미기재
Publication of KR890003390A publication Critical patent/KR890003390A/ko
Application granted granted Critical
Publication of KR970009582B1 publication Critical patent/KR970009582B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A23L33/165—Complexes or chelates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Medicinal Preparation (AREA)

Abstract

내용 없음

Description

골다공증 및 관련된 장해의 치료방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (6)

  1. 칼슘 시트레이트 말레이트를 함유함을 특징으로 하는, 인간 또는 기타 동물 대상자의 뼈 조직을 치료하거나 형성하는데 사용하기 위한 조성물.
  2. 제1항에 있어서, 칼슘 시트레이트 말레이트가 1:0.5 내지 1:4.5의 시트레이트 : 말레이트의 몰비를 갖는 조성물.
  3. 제2항에 있어서, 칼슘 시트레이트 말레이트가 1:0.75 내지 1:3의 시트레이트 : 말레이트의 몰비를 갖는 조성물.
  4. 제2항에 있어서, 칼슘 시트레이트 말레이트가 1:0.7 내지 1:0.9의 칼슘 : 시트레이트+말레이트의 몰비를 갖는 조성물.
  5. 제1항에 있어서, 골다공증을 치료하기 위한 조성물.
  6. 제2항에 있어서, 칼슘 시트레이트 말레이트 중의 칼슘의 몰 당량이 칼슘 시트레이트 말레이트 중의 시트레이트의 몰 당량+말레이트의 몰 당량의 총수와 동일한 조성물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR88010858A 1987-08-28 1988-08-26 Method for the treatment of oste oporosis and related disorders KR970009582B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9100687A 1987-08-28 1987-08-28
US07/091,006 1987-08-28

Publications (2)

Publication Number Publication Date
KR890003390A true KR890003390A (ko) 1989-04-14
KR970009582B1 KR970009582B1 (en) 1997-06-14

Family

ID=22225323

Family Applications (1)

Application Number Title Priority Date Filing Date
KR88010858A KR970009582B1 (en) 1987-08-28 1988-08-26 Method for the treatment of oste oporosis and related disorders

Country Status (9)

Country Link
EP (1) EP0304986B1 (ko)
JP (1) JP2738541B2 (ko)
KR (1) KR970009582B1 (ko)
AT (1) ATE88633T1 (ko)
CA (1) CA1329774C (ko)
DE (1) DE3880587T2 (ko)
HK (1) HK94096A (ko)
IE (1) IE61451B1 (ko)
PH (1) PH25585A (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5108761A (en) * 1990-10-01 1992-04-28 The Procter & Gamble Company Method of preventing tooth enamel erosion utilizing an acidic beverage containing calcium
CA2093013A1 (en) * 1990-10-31 1992-05-01 Mary Mora Fox Calcium fortified sauces
US5389387A (en) * 1991-12-26 1995-02-14 The Procter & Gamble Company Storage stable calcium-supplemented beverage concentrates
CA2123604C (en) * 1991-12-26 1998-02-17 Alice Lyles Burkes Storage stable calcium-supplemented beverage concentrates
AU4597293A (en) * 1992-06-30 1994-01-24 Procter & Gamble Company, The Effervescent calcium supplements
EP0788318B1 (en) * 1992-10-21 2000-12-20 The Procter & Gamble Company Concentrated bioavailable calcium source
WO1994008471A1 (en) * 1992-10-21 1994-04-28 The Procter & Gamble Company Sweetener containing a concentrated bioavailable calcium source
JP3199743B2 (ja) * 1992-10-21 2001-08-20 ザ、プロクター、エンド、ギャンブル、カンパニー カルシウムを補給した貯蔵安定な飲料用濃縮プレミックス及びシロップ
IT1256300B (it) * 1992-11-05 1995-11-29 Dompe Farmaceutici Spa Uso di acidi aril-, eteroaril- e alchiltartronici come agenti terapeutici
EP1117306A2 (en) * 1998-09-29 2001-07-25 The Procter & Gamble Company Low acid beverages supplemented with nutritional calcium sources
US6811800B2 (en) 1998-09-29 2004-11-02 The Procter & Gamble Co. Calcium fortified beverages
JP4762346B2 (ja) * 2006-08-17 2011-08-31 ザ プロクター アンド ギャンブル カンパニー クエン酸リンゴ酸カルシウムを含む組成物及びその製造方法
TR200908237A2 (tr) 2009-11-02 2011-05-23 Bi̇lgi̇ç Mahmut Kalsiyum ve D vitamini içeren farmasötik bileşimler.
MX2013010622A (es) * 2011-03-16 2014-08-18 Charlotte Mecklenburg Hospital Composiciones y métodos para el tratamiento de enfermedades y transtornos relacionados con el tejido musculoesquelético utilizando complejos de análogo de citrato de ion metálico.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5697248A (en) * 1979-12-28 1981-08-05 Tanaka Shiro Conjugated compound of calcium citrate and calcium malate and its preparation
FR2601249A1 (fr) * 1986-07-09 1988-01-15 Sandoz Lab Nouvelles compositions pharmaceutiques a base de sels de calcium.
US4786510A (en) * 1987-07-02 1988-11-22 The Procter & Gamble Company Calcium-iron mineral supplements

Also Published As

Publication number Publication date
JP2738541B2 (ja) 1998-04-08
IE61451B1 (en) 1994-11-02
HK94096A (en) 1996-06-07
CA1329774C (en) 1994-05-24
EP0304986A2 (en) 1989-03-01
DE3880587T2 (de) 1993-09-23
JPH01151515A (ja) 1989-06-14
ATE88633T1 (de) 1993-05-15
KR970009582B1 (en) 1997-06-14
EP0304986A3 (en) 1990-03-07
PH25585A (en) 1991-08-08
DE3880587D1 (de) 1993-06-03
IE882609L (en) 1989-02-28
EP0304986B1 (en) 1993-04-28

Similar Documents

Publication Publication Date Title
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
DE68919358D1 (de) Zusammensetzung zur behandlung der schizophrenie.
KR890003390A (ko) 골다공증 및 관련된 장해의 치료방법
DE69806246D1 (de) Zusammensetzung enthaltend capsaicin oder seine analogen und lokalanästhetika
ATE130762T1 (de) Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen.
DE59102210D1 (de) Galanthemin enthaltende pharmazeutische Formulierung zur Behandlung des Alkoholismus.
ATE82120T1 (de) Kalziumzusaetze.
ATE137965T1 (de) Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege
DE3685853D1 (de) Mittel zur behandlung von knochenkrankheiten.
DE69420776T2 (de) Idebenone-haltige Zusammensetzungen zur Behandlung von M. Alzheimer
KR880009656A (ko) 국소 치근막 질환의 치료 또는 예방법
KR900017599A (ko) 종양 치료용 약학 조성물
DE3879489D1 (de) Pharmazeutische kompositionen zum behandeln von adrenoleukodystrophie.
KR930702016A (ko) 골다공증 치료제
KR890007737A (ko) 진토작용을 하는 약제
FR2635006B1 (fr) Medicament destine a regulariser les secretions hormonales et a traiter la sterilite
KR890001555A (ko) 요산 배설용 조성물
DE3776662D1 (de) Pharmazeutische zusammensetzungen zur behandlung von hyperproliferativer hautkrankheit.
KR890014121A (ko) 사람의 골공증(骨孔症) 치료를 위한 방법과 조성물

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20111019

Year of fee payment: 15

EXPY Expiration of term